55.80
price up icon1.58%   0.885
 
loading
Schlusskurs vom Vortag:
$54.91
Offen:
$55.84
24-Stunden-Volumen:
625.67K
Relative Volume:
0.27
Marktkapitalisierung:
$137.99B
Einnahmen:
$48.03B
Nettoeinkommen (Verlust:
$6.06B
KGV:
22.33
EPS:
2.4983
Netto-Cashflow:
$9.91B
1W Leistung:
-1.97%
1M Leistung:
+2.40%
6M Leistung:
-3.24%
1J Leistung:
+14.77%
1-Tages-Spanne:
Value
$55.62
$55.95
1-Wochen-Bereich:
Value
$53.98
$56.93
52-Wochen-Spanne:
Value
$45.22
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Firmenname
Sanofi Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
@sanofi
Name
Nächster Verdiensttermin
2024-10-25
Name
Neueste SEC-Einreichungen
Name
SNY's Discussions on Twitter

Vergleichen Sie SNY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
SNY
Sanofi Adr
55.80 137.99B 48.03B 6.06B 9.91B 2.4983
Drug Manufacturers - General icon
LLY
Lilly Eli Co
822.90 741.33B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
202.39 359.10B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
JNJ
Johnson Johnson
164.22 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
69.94 311.44B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
MRK
Merck Co Inc
89.42 223.02B 64.17B 17.12B 18.10B 6.73

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-21 Eingeleitet Goldman Neutral
2025-01-30 Hochstufung Deutsche Bank Sell → Hold
2024-07-26 Bestätigt Argus Buy
2024-01-23 Eingeleitet Morgan Stanley Equal-Weight
2024-01-16 Fortgesetzt UBS Buy
2023-12-05 Herabstufung JP Morgan Overweight → Neutral
2023-10-30 Herabstufung Stifel Buy → Hold
2023-09-06 Hochstufung Berenberg Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Buy
2023-04-28 Herabstufung Deutsche Bank Hold → Sell
2023-03-27 Hochstufung Barclays Equal Weight → Overweight
2022-12-13 Fortgesetzt Morgan Stanley Overweight
2022-08-12 Hochstufung Deutsche Bank Sell → Hold
2022-08-09 Herabstufung UBS Buy → Neutral
2022-05-23 Eingeleitet SVB Leerink Outperform
2021-09-27 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-01-15 Eingeleitet Deutsche Bank Sell
2020-09-29 Eingeleitet Berenberg Hold
2020-03-17 Hochstufung Barclays Underweight → Equal Weight
2020-03-11 Hochstufung Goldman Neutral → Buy
2020-02-11 Eingeleitet SVB Leerink Mkt Perform
2020-01-06 Hochstufung JP Morgan Neutral → Overweight
2019-09-23 Hochstufung Guggenheim Neutral → Buy
2019-09-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-03 Eingeleitet Bernstein Outperform
2019-08-14 Hochstufung UBS Neutral → Buy
2018-12-11 Hochstufung Jefferies Hold → Buy
2018-11-01 Hochstufung Barclays Underweight → Equal Weight
2018-10-09 Eingeleitet Guggenheim Neutral
2018-09-10 Hochstufung BofA/Merrill Neutral → Buy
2018-08-10 Hochstufung Citigroup Neutral → Buy
2018-03-23 Hochstufung Liberum Hold → Buy
2018-01-23 Herabstufung Barclays Equal Weight → Underweight
2017-12-06 Herabstufung BofA/Merrill Buy → Neutral
2017-12-01 Herabstufung Morgan Stanley Overweight → Underweight
2017-11-15 Hochstufung Barclays Underweight → Equal Weight
2017-08-30 Hochstufung HSBC Securities Reduce → Hold
Alle ansehen

Sanofi Adr Aktie (SNY) Neueste Nachrichten

pulisher
Mar 27, 2025

Led by Dupixent, Solid Immunology Position Helps Support Steady Long-Term Growth for Sanofi - Morningstar

Mar 27, 2025
pulisher
Mar 26, 2025

[Latest] Global Fabry Disease Treatment Market Size/Share Worth USD 7.02 Billion by 2034 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.

Mar 26, 2025
pulisher
Mar 26, 2025

4 healthcare stocks attractive on valuation and ESG risk - Morningstar.com.au

Mar 26, 2025
pulisher
Mar 18, 2025

SNY Quantitative Stock Analysis - Nasdaq

Mar 18, 2025
pulisher
Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 12, 2025

Know Labs Inc (KNW) Stock: A Closer Look at the Market Potential - The News Heater

Mar 12, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Feb 27, 2025

Piper Sandler Shows Market Leadership With Jump To 83 RS Rating - Inkl

Feb 27, 2025
pulisher
Feb 26, 2025

Sanofi ADR Shows Market Leadership With Jump To 82 RS Rating - Investor's Business Daily

Feb 26, 2025
pulisher
Feb 25, 2025

Gold Field ADR Sees Its Composite Rating Rise To 99 - Inkl

Feb 25, 2025
pulisher
Feb 24, 2025

ZEEKR Intelligent ADR Shows Rising Price Performance With Jump To 80 RS Rating - Inkl

Feb 24, 2025
pulisher
Feb 17, 2025

Validea Detailed Fundamental AnalysisSNY - Nasdaq

Feb 17, 2025
pulisher
Feb 14, 2025

Harrow Earns Relative Strength Rating Upgrade - Inkl

Feb 14, 2025
pulisher
Feb 13, 2025

Sanofi ADR Earns RS Rating Upgrade - Investor's Business Daily

Feb 13, 2025
pulisher
Feb 11, 2025

Newmont Earns RS Rating Upgrade - Inkl

Feb 11, 2025
pulisher
Feb 07, 2025

What was Skechers U S A, Inc (SKX)’s performance in the last session? - US Post News

Feb 07, 2025
pulisher
Feb 07, 2025

Sanofi ADR (SNY) requires closer examination - US Post News

Feb 07, 2025
pulisher
Feb 05, 2025

Sanofi ADR (SNY): A Technical Analysis - The News Heater

Feb 05, 2025
pulisher
Feb 05, 2025

GNPX’s Market Whiplash: -38.94% YTD Decline, -42.28% Plunge in 30 Days - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

Applied Materials Inc’s Banking’s 100-Day Moving Average at 182.60: Will the Stock Break Through? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 05, 2025

ESPR’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 05, 2025
pulisher
Feb 04, 2025

Regeneron Pharmaceuticals Beats On Libtayo's Back, Unveils Dividend - Investor's Business Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Waltham biotech plans to raise $150M in IPO this week - The Business Journals

Feb 03, 2025
pulisher
Jan 30, 2025

Sanofi Reports Strong Q4 Sales Growth, Plans €5 Billion Buyback in 2025 - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR earnings beat by $0.53, revenue fell short of estimates - Investing.com South Africa

Jan 30, 2025
pulisher
Jan 30, 2025

Sanofi ADR (SNY) Recovers 15.33% From Low: Are We There Yet? - Stocks Register

Jan 30, 2025
pulisher
Jan 29, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Jan 29, 2025
pulisher
Jan 25, 2025

AECOM (NYSE: ACM) Is A Blank Check For Growth - Stocks Register

Jan 25, 2025
pulisher
Jan 25, 2025

Shares Of Pennymac Mortgage Investment Trust (NYSE: PMT): Are They Overvalued Compared To Others? - Stocks Register

Jan 25, 2025

Finanzdaten der Sanofi Adr-Aktie (SNY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$111.06
price up icon 1.73%
drug_manufacturers_general PFE
$25.00
price down icon 0.10%
$307.32
price up icon 0.41%
drug_manufacturers_general NVS
$111.65
price up icon 0.25%
drug_manufacturers_general MRK
$89.28
price up icon 1.91%
Kapitalisierung:     |  Volumen (24h):